...
首页> 外文期刊>Journal of biomedical science. >Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination
【24h】

Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination

机译:接种单剂量疫苗的BALB / c小鼠中的猪源流感病毒(S-OIV)H1N1和重配H5N1流感疫苗的交叉保护特性

获取原文
           

摘要

BackgroundInfluenza virus has antigen drift and antigen shift effect, vaccination with some influenza vaccine might not induce sufficient immunity for host to the threat of other influenza virus strains. S-OIV H1N1 and H5N1 influenza vaccines in single-dose immunization were evaluated in mice for cross protection to the challenge of A/California/7/2009 H1N1 or NIBRG-14 H5N1 virus.ResultsBoth H1N1 and H5N1 induced significant homologous IgG, HAI, and microneutralization antibody responses in the mice, while only vaccines plus adjuvant produced significant heterogeneous IgG and HAI antibody responses. Both alum and MPLA adjuvants significantly reduced the S-OIV H1N1 vaccine dose required to elicit protective HAI antibody titers from 0.05?μg to 0.001?μg. Vaccines alone did not protect mice from challenge with heterogeneous influenza virus, while H5N1 vaccine plus alum and MPLA adjuvants did. Mouse body weight loss was also less significant in the presence of adjuvant than in the vaccine without adjuvant. Furthermore, both H1N1 and H5N1 lung viral titers of immunized mice were significantly reduced post challenge with homologous viruses.ConclusionOnly in the presence of MPLA adjuvant could the H5N1 vaccine significantly reduce mouse lung viral titers post H1N1 virus challenge, and not vice versa. MPLA adjuvant induced cross protection with a single dose vaccination to the challenge of heterogeneous influenza virus in mice. Lung viral titer seemed to be a better indicator compared to IgG, neutralization antibody, and HAI titer to predict survival of mice infected with influenza virus.
机译:背景流感病毒具有抗原漂移和抗原转移作用,接种某些流感疫苗可能无法为宿主抵抗其他流感病毒株的威胁诱导足够的免疫力。在小鼠中评估了单剂量免疫接种的S-OIV H1N1和H5N1流感疫苗对A / California / 7/2009 H1N1或NIBRG-14 H5N1病毒的交叉保护作用。结果H1N1和H5N1均可诱导显着的同源IgG,HAI,和疫苗中的微中和抗体反应,而只有疫苗和佐剂才产生明显的异质IgG和HAI抗体反应。明矾和MPLA佐剂均可将引起保护性HAI抗体滴度所需的S-OIV H1N1疫苗剂量从0.05?μg降低至0.001?μg。单独的疫苗不能保护小鼠免受异种流感病毒的攻击,而H5N1疫苗加明矾和MPLA佐剂可以保护小鼠。在存在佐剂的情况下,小鼠的体重减轻也没有在没有佐剂的疫苗中的显着减轻。此外,用同源病毒攻击后,免疫小鼠的H1N1和H5N1肺病毒滴度均显着降低。结论只有在MPLA佐剂存在下,H5N1疫苗才能显着降低H1N1病毒攻击后的小鼠肺病毒滴度,反之亦然。 MPLA佐剂通过单次接种疫苗即可诱导交叉保护,以应对小鼠中异种流感病毒的攻击。与IgG,中和抗体和HAI滴度相比,肺病毒滴度似乎是更好的指标,可以预测感染流感病毒的小鼠的存活率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号